- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Treatment
- Study type descriptors: Retrospective, Single centre
- Objective: To compare the outcome of patients treated with a “rheumatological approach” including 6-methylprednisolone pulses followed by rapid tapering and baricitinib to that of critically ill COVID-19 patients treated with a “conventional approach” consisting of dexamethasone plus remdesevir
- Number of participants enrolled: 246
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults (18-64 years)
- Elderly (≥65 years)
- Fragile population
- Hospital
- Intensive care unit
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Remdesivir
- Immunomodulator
- Steroids
- Baricitinib
- Dexamethasone
- Methylprednisolone
External Links
Other information
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to